Researchers Quantify Magnitude of Cardiovascular Risk Associated With Cannabis
By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 18, 2025 -- Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online June 17 in Heart.
Wilhelm Storck, from the University of Toulouse in France, and colleagues examined the possible association between MACE and the use of cannabis or cannabinoids in a review of pharmacoepidemiological studies published from Jan. 1, 2016, to Jan. 31, 2023. Twenty-four articles, including 17 cross-sectional studies, six cohort studies, and one case-control study, were reviewed.
In all studies, exposure corresponded to use of cannabis, with one study focused on medical cannabis. The researchers found that the estimated risk ratios were 1.29, 1.20, and 2.10 for nonfatal acute coronary syndrome (ACS), stroke, and cardiovascular death, respectively. No significant association was seen for the composite outcome combining ACS and stroke as measured in two studies. Results for the focused analysis restricted to cohort studies were comparable to the primary model (risk ratio, 1.32).
"Cannabis needs to be incorporated into the framework for prevention of clinical cardiovascular disease," write the authors of an accompanying editorial. "Cardiovascular and other health risks must be considered in the regulation of allowable product and marketing design as the evidence base grows. Today that regulation is focused on establishing the legal market with woeful neglect of minimizing health risks. Specifically, cannabis should be treated like tobacco: not criminalized, but discouraged, with protection of bystanders from secondhand exposure."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-19 06:00
Read more

- Incyte Announces FDA Approval of Monjuvi (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma
- CT Colonography Cost-Effective, Clinically Effective for CRC Screening
- Blood Pressure Diet Helps Type 2 Diabetics
- Trump Administration To End Lifeline for LGBTQ+ Youth This July
- Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years
- Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions